WGS - Latest News

GeneDx Holdings Corp. (WGS), operates in Healthcare / Medical - Healthcare Information Services, trades on NASDAQ.

Market capitalization stands near $1.96B. Beta to the broader market is 1.91.

The article list below shows the most recent WGS headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent WGS Headlines

GeneDx to Report Second Quarter 2026 Financial Results on Monday, August 3, 2026

businesswire.com - Jul 16, 2026

GAITHERSBURG, Md. --(BUSINESS WIRE)--GeneDx (Nasdaq: WGS) announced it will release financial results for the second quarter of 2026 after the market

WGS DEADLINE ALERT: Robbins Geller Rudman & Dowd LLP Announces that GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - August 3, 2026 Deadline

globenewswire.com - Jul 16, 2026

SAN DIEGO, July 16, 2026 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of GeneDx Holdings Corp. (NAS

GeneDx Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against GeneDx Holdings Corp. - WGS

globenewswire.com - Jul 16, 2026

NEW ORLEANS, July 16, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until August 3, 2

WGS DEADLINE: SueWallSt Reminds GeneDx Holdings Corp. Investors of Upcoming Securities Class Action Deadline

prnewswire.com - Jul 16, 2026

Important Information Regarding Section 20(a) Individual Liability Claims Against GeneDx CEO and CFO for Alleged $33. 42 Per-Share Investor Losses Tie

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GeneDx Holdings Corp. of Class Action Lawsuit and Upcoming Deadlines - WGS

prnewswire.com - Jul 16, 2026

NEW YORK, July 16, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against GeneDx Holdings Corp. ("GeneDx" or

How News Affects WGS Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track WGS's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked WGS news questions

What is the latest WGS news headline?
The most recent WGS headline (Jul 16, 2026) is "GeneDx to Report Second Quarter 2026 Financial Results on Monday, August 3, 2026". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
How fresh is the WGS news on this page?
News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
What WGS news moves options pricing?
Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
How can I track unusual WGS options activity related to news?
Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.